Stock comparison
AbbVie Inc. is 1.5x more valuable than AstraZeneca PLC by market capitalization ($440.14 B vs $286.27 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 1.5x more valuable than AstraZeneca PLC by market capitalization ($440.14 B vs $286.27 B).
Market value leader
ABBV
AbbVie Inc. is 1.5x more valuable than AstraZeneca PLC by market capitalization ($440.14 B vs $286.27 B).
| Metric | ABBV | AZN |
|---|---|---|
| Market cap | $440.14 B | $286.27 B |
| US-listed rank | #25 | #50 |
| Revenue (latest FY) | $61.16B | - |
| Net income (latest FY) | $4.23B | - |
| Net margin | 6.9% | - |
| P/E (trailing FY) | 104.2x | - |
| SEC filings | 1,008 | 1,004 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 1.5x more valuable than AstraZeneca PLC by market capitalization ($440.14 B vs $286.27 B).
Full pages: AbbVie Inc. and AstraZeneca PLC, or browse the full rankings.